Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jun 12 2023

Full Issue

Health Officials Push For Maximizing Potential Of Fentanyl Test Strips

The government's top addiction scientists and key public health officials are asking for more research into how fentanyl test strips could be better used, for clinical purposes as well as overdose prevention. Separately, a $17 billion opioid settlement was reached.

Stat: Top Health Officials Call For More Research On Fentanyl Test Strips

The government’s top addiction scientists and key public health officials are calling for more research into fentanyl test strips. Amid a devastating overdose epidemic, the U.S. must ensure that test strips are legal and widely available, the officials wrote in a New England Journal of Medicine perspective published Saturday. Additionally, they argued, the U.S. should work to develop new products and technologies that facilitate drug-checking. (Facher, 6/10)

Also —

Stat: Drug Companies, Pharmacies Reach $17B Opioid Settlement

Two large drugmakers and two of the biggest pharmacy chains finalized a $17.3 billion deal to settle accusations by state governments that they contributed to the opioid crisis that swept across the U.S. for more than a decade and contributed to thousands of overdose deaths. (Silverman, 6/9)

AP: Abstinence Not Required: How A Baltimore Drug Treatment Program Prioritizes Saving Lives 

The so-called harm reduction model, which has received endorsement and funding from the Biden administration, offers potentially life-saving services to opioid users, without requiring abstinence in return. Advocates say it acknowledges the importance of keeping people alive, first and foremost, while they confront the sometimes insurmountable challenges associated with recovery. Critics argue it enables illegal activity. (Skene, 6/11)

The Wall Street Journal: Recovering From Drug Addiction Was Hard. Tranq Made It Worse

David “Lee” Wells marveled at how it felt to hold an iced coffee in his hand again after losing his fingers to “tranq” wounds that rotted away his flesh. He flashed a cheeky grin and took a selfie with his new titanium fingers wrapped around the cup. “This is the aftermarket me,” he said. This is what recovery looks like for drug users disfigured by xylazine, or “tranq,” an animal tranquilizer mixed into America’s increasingly toxic illicit drug supply. (Wernau, 6/11)

Los Angeles Times: A Metro Worker Revived 21 Riders Overdosing On Opioids

Walking along a rail platform, a veteran transit worker spotted a package of the opioid overdose-reversing drug naloxone, picked it up and slipped it in his vest. He couldn’t imagine that he would use the medicine less than two hours later. But looking back on that evening in February 2022, it shouldn’t have been a surprise. (Uranga, 6/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF